featured
Effect of the Addition of an Antistaphylococcal β-Lactam in MRSA Bacteremia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial
JAMA 2020 Feb 11;323(6)527-537, SYC Tong, DC Lye, D Yahav, A Sud, JO Robinson, J Nelson, S Archuleta, MA Roberts, A Cass, DL Paterson, H Foo, M Paul, SD Guy, AR Tramontana, GB Walls, S McBride, N Bak, N Ghosh, BA Rogers, AP Ralph, J Davies, PE Ferguson, R Dotel, GL McKew, TJ Gray, NE Holmes, S Smith, MS Warner, S Kalimuddin, BE Young, N Runnegar, DN Andresen, NA Anagnostou, SA Johnson, MD Chatfield, AC Cheng, VG Fowler, BP Howden, N Meagher, DJ Price, SJ van Hal, MVN O'Sullivan, JS DavisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.